A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma - (FIGHT-201)
Public ClinicalTrials.gov record NCT02872714. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Open-Label, Single-Agent, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Metastatic or Surgically Unresectable Urothelial Carcinoma Harboring FGF/FGFR Alterations - (FIGHT-201)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the overall response rate (ORR) of pemigatinib as a monotherapy in the treatment of metastatic or surgically unresectable urothelial carcinoma harboring FGF/FGFR alterations.
Study identification
- NCT ID
- NCT02872714
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 263 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 12, 2017 (Actual)
- Primary completion
- Feb 1, 2022 (Actual)
- Completion
- Feb 1, 2022 (Actual)
- Last update posted
- Aug 14, 2025
2017 – 2022
United States locations
- U.S. sites
- 34
- U.S. states
- 22
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Oncology Associates (Wilmot) | Tucson | Arizona | 85711 | — |
| Sharp Memorial Hospital | San Diego | California | 92123 | — |
| UCSF Helen Diller Family Comprehensive Care Center | San Francisco | California | 94158 | — |
| Rocky Mountain Cancer Centers | Boulder | Colorado | 80303 | — |
| Calaway-Young Cancer Center at Valley View Hospital | Glenwood Springs | Colorado | 81601 | — |
| Mount Sinai Medical Center | Miami Beach | Florida | 33140 | — |
| Florida Hospital Cancer Institute | Orlando | Florida | 32804 | — |
| Emory University School of Medicine | Atlanta | Georgia | 30322 | — |
| University of Maryland, Greenebaum Cancer Center | Baltimore | Maryland | 21201 | — |
| Lahey Clinic Inc. - PARENT ACCOUNT | Burlington | Massachusetts | 01805 | — |
| Minnesota Oncology Hematology, P.A. | Woodbury | Minnesota | 55125 | — |
| GU Research Network | Omaha | Nebraska | 68130 | — |
| TRIO - Comprehensive Cancer Centers of Nevada | Las Vegas | Nevada | 89169-3321 | — |
| New York Oncology Hematology, P.C. | Albany | New York | 12208 | — |
| Northwell Cancer Institute | New Hyde Park | New York | 11042 | — |
| University of Rochester | Rochester | New York | 14642 | — |
| University of North Carolina at Chapel Hill | Chapel Hill | North Carolina | 27514 | — |
| Oncology Hematology Care, Inc. | Cincinnati | Ohio | 45242 | — |
| Oregon Health & Science University | Portland | Oregon | 97229 | — |
| Compass Oncology the Northwest Cancer Specialists | Tualatin | Oregon | 97062 | — |
| St. Luke's Hospital | Bethlehem | Pennsylvania | 18015 | — |
| VA Pittsburgh Healthcare System | Pittsburgh | Pennsylvania | 15240 | — |
| Carolina Urologic Research Center | Myrtle Beach | South Carolina | 29572 | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | — |
| Texas Oncology, P.A. - Austin | Austin | Texas | 78731 | — |
| Texas Oncology - Baylor Charles A. Sammons | Dallas | Texas | 75246 | — |
| Texas Oncology | Houston | Texas | 77024 | — |
| Texas Oncology, P.A. - Sherman | Sherman | Texas | 75090 | — |
| Baylor Scott & White Health | Temple | Texas | 76508 | — |
| Huntsman Cancer Institute | Salt Lake City | Utah | 84112 | — |
| Virginia Oncology Associates - Hampton | Norfolk | Virginia | 23502 | — |
| Northwest Medical Specialties, PLLC | Tacoma | Washington | 98405 | — |
| University of Wisconsic Hospital and Clinic | Madison | Wisconsin | 53792 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 62 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02872714, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 14, 2025 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02872714 live on ClinicalTrials.gov.